Study Says Decentralized Trials Rebounded More Quickly from COVID-19 Disruptions

A new study confirms what many suspected about a tumultuous year for conducting clinical trials: Patient recruitment and retention dropped across the industry in early 2020, due to global quarantines and stay-at-home orders. However, the study also found decentralized clinical trials (DCTs) rapidly returned to pre-pandemic recruitment and retention levels while traditionally designed clinical trials […]

Looking Forward to a Future with No More Needles

Blood draws are no fun. They hurt. Veins can burst, or even roll—like they’re trying to avoid the needle, too. However, clinical trial protocols often include instructions for regular blood draws throughout the course of a study. Principal investigators for trials and doctors in regular clinical practice use blood samples to check for biomarkers of […]

CDER Outlines Drug Safety Measures Taken in 2020

“The past year was an unprecedented one,” says Patrizia Cavazzoni, MD, acting director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA), in a new report on the center’s activities in 2020. She notes CDER “collaborated closely with colleagues across the [FDA] as well as other […]

Javara Joins ACRP Partners in Workforce Advancement

The Association of Clinical Research Professionals (ACRP) welcomes Javara as a Workforce Champion member of the Partners in Workforce Advancement. Partners in Workforce Advancement is a multi-stakeholder collaborative initiative to grow and expand the diversity of the clinical research workforce, and to set and support standards for workforce competence. “Organizations aligned with ACRP’s mission […]